Hepatitis B surface antigen (HBsAg) prevalence in Naoero
Naoero: Hepatitis B surface antigen (HBsAg) prevalence was 0.6% in 2024. ▼ Falling
Latest (2024)
0.6%
Change on year
unchanged
World rank
51st
of 194 countries
All-time high
1.3%
in 2015
All-time low
0.6%
in 2022
Years of data
10
2015–2024
Hepatitis B surface antigen (HBsAg) prevalence in Naoero, 2015–2024
Source: World Health Organization, Global Health Observatory.
Analysis
Naoero recorded 0.6% for hepatitis b surface antigen (hbsag) prevalence in 2024. That is the lowest value across all 10 years on record.
Compared with earlier readings it is down 53.8% over ten years.
Over the whole period, hepatitis b surface antigen (hbsag) prevalence in Naoero peaked at 1.3% in 2015 and was at its lowest, 0.6%, in 2022.
That places Naoero 51st out of 194 countries with data for 2024, putting it in the middle of the range.
Hepatitis B surface antigen (HBsAg) prevalence in Naoero, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 1.3% | — |
| 2016 | 1.2% | -7.7% |
| 2017 | 1.2% | +0.0% |
| 2018 | 1.1% | -8.3% |
| 2019 | 1.0% | -9.1% |
| 2020 | 0.8% | -20.0% |
| 2021 | 0.7% | -12.5% |
| 2022 | 0.6% | -14.3% |
| 2023 | 0.6% | +0.0% |
| 2024 | 0.6% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 1.2% | 1.0% | 1.3% | 5 |
| 2020s | 0.7% | 0.6% | 0.8% | 5 |
Countries ranked near Naoero
- 51 Tonga 0.6% compare
- 51 Côte d'Ivoire 0.6% compare
- 51 Ethiopia 0.6% compare
- 51 Micronesia, Federated States of 0.6% compare
- 51 Lao People's Democratic Republic 0.6% compare
- 51 Madagascar 0.6% compare
- 51 Palau 0.6% compare
More health data for Naoero
- Heat deaths vs projected death rates 1,118 (2090)
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.8477 % change on previous year (2090)
- Un projection of annual infant deaths 2 (2100)
- Age population, age 07, female, interpolated 137 (2025)
- Age population, age 09, male, interpolated 160 (2025)
- Age population, age 09, female, interpolated 147 (2025)
- Age population, age 08, male, interpolated 157 (2025)
- Age population, age 08, female, interpolated 141 (2025)
- Age population, age 07, male, interpolated 149 (2025)
Frequently asked questions
- What is hepatitis b surface antigen (hbsag) prevalence in Naoero?
- Hepatitis b surface antigen (hbsag) prevalence in Naoero was 0.6% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hepatitis b surface antigen (hbsag) prevalence recorded in Naoero?
- The highest recorded value was 1.3% in 2015.
- What is the lowest hepatitis b surface antigen (hbsag) prevalence recorded in Naoero?
- The lowest recorded value was 0.6% in 2022.
- How does Naoero rank for hepatitis b surface antigen (hbsag) prevalence?
- Naoero ranks 51st out of 194 countries with data for 2024.
- Is hepatitis b surface antigen (hbsag) prevalence rising or falling in Naoero?
- Over the last ten years it is down 53.8%. The long-run trend across the full record is falling.
- Where does this Naoero data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).